As a biocluster, Lyonbiopole is the gateway to healthcare innovation in Auvergne Rhône-Alpes, France, and the leading biocluster in France. It aims to support the emergence and development of innovative technologies, products and services in 4 main strategic areas : human medicine, veterinary medicine, in vitro diagnostics, medical devices and medical technologies. 

Lyonbiopole is supporting ambitious projects and companies in many fields like infectious diseases, cancer, nutrition, metabolic diseases and neurosciences. 

In 2019, Lyonbiopole represented a community of 245 members: 6 world-class founders (Sanofi Pasteur, bioMérieux, Boehringer Ingelheim, Becton Dickinson, CEA, Fondation Mérieux), 16 large group subsidiaries, 19  Research Centers including 3 University Hospital Centers and 204 SMEs. Lyonbiopole has been awarded the Gold label by the “European Cluster Excellence Initiative”.